(Reuters) - The White House is holding onto some doses of AstraZeneca Plc's COVID-19 vaccine so they can be given to Americans quickly if authorized by the U.S. health regulator, a top administration official said Friday.
AstraZeneca has produced doses of its COVID-19 vaccine in the United States, where it has yet to be approved. The vaccine developed with Oxford University has been authorized for use in the European Union and many other countries.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!